share_log

A Glimpse Into The Expert Outlook On Omega Therapeutics Through 4 Analysts

A Glimpse Into The Expert Outlook On Omega Therapeutics Through 4 Analysts

通過四位分析師的專業觀點,了解Omega Therapeutics的前景
Benzinga ·  08/15 21:00
Throughout the last three months, 4 analysts have evaluated Omega Therapeutics (NASDAQ:OMGA), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中,4位分析師評估了Omega Therapeutics(納斯達克股票代碼:OMGA),提供了從看好到看淡的多樣觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖,顯示了過去30天的不同情緒,並將其與前幾個月進行比較。
Analysts have set 12-month price targets for Omega Therapeutics, revealing an average target of $10.5, a high estimate of $12.00, and a low estimate of $6.00. This current average reflects an increase of 1.65% from the previous average price target of $10.33.
分析師爲Omega Therapeutics設定了12個月的價格目標,揭示了平均目標爲10.5美元,最高估值爲12美元,最低估值爲6美元。當前平均價格比上一個價格目標的10.33美元上漲1.65%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
A clear picture of Omega Therapeutics's perception...
通過對分析師近期...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論